Catalysts for Avyxa Pharma LLC
11 tracked
Feb 20, 2026
approval
FAVLYXA (FLUOROURACIL) โ FDA approval
Efudex
โ
Feb 13, 2026
approval
AVOPEF (ETOPOSIDE) โ FDA approval
etoposide
โ
Feb 3, 2026
approval
VYKOURA (LEUCOVORIN CALCIUM) โ FDA approval
LEUCOVORIN CALCIUM
โ
Nov 21, 2025
approval
FULVESTRANT โ FDA approval
FULVESTRANT
โ
Oct 3, 2025
approval
AXTLE (PEMETREXED DIPOTASSIUM) โ FDA approval
AXTLE
โ
Jun 18, 2025
approval
AXTLE (PEMETREXED DIPOTASSIUM) โ FDA approval
AXTLE
โ
Dec 2, 2024
approval
AXTLE (PEMETREXED DIPOTASSIUM) โ FDA approval
AXTLE
โ
Jun 28, 2024
approval
AXTLE (PEMETREXED DIPOTASSIUM) โ FDA approval
AXTLE
โ
Nov 12, 2021
approval
FULVESTRANT โ FDA approval
FULVESTRANT
โ
Apr 6, 2021
approval
FULVESTRANT โ FDA approval
FULVESTRANT
โ
Aug 19, 2019
approval
FULVESTRANT โ FDA approval
FULVESTRANT
โ